Functional significance of mesolimbic dopamine
Neuroscience & Biobehavioral Reviews, ISSN: 0149-7634, Vol: 19, Issue: 4, Page: 573-598
1995
- 123Citations
- 59Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations123
- Citation Indexes122
- 122
- CrossRef79
- Policy Citations1
- Policy Citation1
- Captures59
- Readers59
- 59
Article Description
Although a large body of neuropharmacological evidence suggests that the mesolimbic dopamine system (ML DA) is critical for goal-directed behaviors, exactly which aspects of behavior are mediated or modulated by this system remains a matter of conjecture. By measuring changes in DA cell firing patterns and extracellular DA concentrations in target areas of ML DA cells during the development and performance of goal-directed behavior, it is possible to directly examine the relationship between ML DA transmission and various stages and components of behavior. This permits tests of hypotheses concerned with the functional significance of ML DA. This review will discuss recent electrophusiological, microdialysis and electrochemical data on behavior-associated changes in firing activity of ML DA cells and fluctuations in DA concentrations in target areas of these cells. Although application of an electrochemical technique to study behavior-associated changes in DA transmission is an area of hot debates, a close correlation between DA-dependent electrochemical signal changes and separate behavioral components, with a generally similar pattern of rapid signal fluctuations found in trained animals during operant lever-pressing behavior maintained by palatable food, cocaine or heroin, suggests that extrasynaptic DA may have some important functions in regulating behavior. This review will discuss possible mechanisms underlying phasic and tonic changes in ML DA transmission accompanying development and performance of positively-reinforced behavior, the contribution of learning, behavioral and pharmacological variables in the mediation of these changes, and their relevance for the organization and regulation of goal-directed behavior.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/0149763495000291; http://dx.doi.org/10.1016/0149-7634(95)00029-1; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0028864189&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/8684717; https://linkinghub.elsevier.com/retrieve/pii/0149763495000291; http://dx.doi.org/10.1016/0149-7634%2895%2900029-1; https://dx.doi.org/10.1016/0149-7634%2895%2900029-1
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know